Table: Wakamoto Pharm - 6-MTH parent results

Wakamoto Pharmaceutical Co

06/11/2025 06:32

Nov 6 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2025        Sep 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.38                3.81             10.00    
                 (+14.9 pct)         (+5.3 pct)       (+28.4 pct) 
  Operating     loss 195 mln        loss 276 mln        200 mln   
  Recurring     loss 175 mln        loss 256 mln        250 mln   
  Net           loss 134 mln        loss 141 mln        200 mln   
                                                     (+210.4 pct) 
  EPS           loss 3.86 yen       loss 4.08 yen      5.76 yen   
  Ann Div                             3.00 yen         3.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             3.00 yen         3.00 yen   
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T